documents: FDA-2014-E-0182-0006

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-E-0182-0006 FDA FDA-2014-E-0182 Determination of Regulatory Review Period for Purposes of Patent Extension; VIZAMYL Notice Determinations 2015-12-15T05:00:00Z 2015 12 2015-12-15T05:00:00Z 2016-02-17T04:59:59Z 2015-12-15T15:50:05Z 2015-31401 0 0 0900006481da740f

Links from other tables